Treatment of inflammatory diseases of the central nervous system
AssigneePalmaya Pty Ltd
InventorAlexander George Brian O'Neil
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of flumazenil for the treatment of inflammatory conditions of the central nervous system, such as migraine, headache and multiple sclerosis, anxiety, PTSD, psychosis, depression, and cessation of addictive behaviours. The active may be administered in the form of an implant. The present invention also relates to the use of flumazenil, naltrexone, and optionally buprenorphine in order to reduce symptoms associated with withdrawal of drugs of dependence or addictive behaviours.
Claims10
A method of treating a patient suffering from a migraine and/or a headache, or multiple sclerosis comprising administering to the patient in need thereof an effective dose of flumazenil to achieve a blood concentration of flumazenil at about 0.5 ng/ml to 3.0 ng/ml flumazenil over a continuous period of time.
Dependencies are inferred from the claim text.